Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
Top Cited Papers
- 1 October 2001
- journal article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 23 (10), 1603-1614
- https://doi.org/10.1016/s0149-2918(01)80132-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Randomized, Double-Blind Study of Triple Nucleoside Therapy of Abacavir, Lamivudine, and Zidovudine Versus Lamivudine and Zidovudine in Previously Treated Human Immunodeficiency Virus Type 1-Infected ChildrenPediatrics, 2001
- PART 1: Executive Summary of Disease Management of Drug Hypersensitivity: A Practice ParameterAnnals of Allergy, Asthma & Immunology, 1999
- New Concepts in Immunology Relevant to Idiosyncratic Drug Reactions: The “Danger Hypothesis” and Innate Immune SystemChemical Research in Toxicology, 1999
- Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adultsAIDS, 1998
- A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patientsAIDS, 1996
- Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?AIDS, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Allergy and desensitization to zidovudine in patients with acquired immunodeficency syndrome (AIDS)Journal of Allergy and Clinical Immunology, 1993
- The Immunologic and Metabolic Basis of Drug HypersensitivitiesAnnual Review of Pharmacology and Toxicology, 1988
- Risk factors for drug allergyJournal of Allergy and Clinical Immunology, 1984